Targeting β-cell dedifferentiation and transdifferentiation: opportunities and challenges
Authors:
Open Access
- 1 August 2021
- journal article
- review article
- Published by Bioscientifica in Endocrine Connections
- Vol. 10 (8) , R213-R228
Abstract
The most distinctive pathological characteristics of diabetes mellitus induced by various stressors or immune-mediated injuries are reductions of pancreatic islet β-cell populations and activity. Existing treatment strategies cannot slow disease progression; consequently, research to genetically engineer β-cell mimetics through bi-directional plasticity is ongoing. The current consensus implicates β-cell dedifferentiation as the primary etiology of reduced β-cell mass and activity. This review aims to summarize the etiology and proposed mechanisms of β-cell dedifferentiation and to explore the possibility that there might be a time interval from the onset of β-cell dysfunction caused by dedifferentiation to the development of diabetes, which may offer a therapeutic window to reduce β-cell injury and to stabilize functionality. In addition, to investigate β-cell plasticity, we review strategies for β-cell regeneration utilizing genetic programming, small molecules, cytokines, and bioengineering to transdifferentiate other cell types into β-cells; the development of biomimetic acellular constructs to generate fully functional β-cell-mimetics. However, the maturation of regenerated β-cells is currently limited. Further studies are needed to develop simple and efficient reprogramming methods for assembling perfectly functional β-cells. Future investigations are necessary to transform diabetes into a potentially curable disease.Keywords
This publication has 100 references indexed in Scilit:
- Generation of functional insulin-producing cells in the gut by Foxo1 ablationNature Genetics, 2012
- Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty ratAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Inhibition of Id1 Augments Insulin Secretion and Protects Against High-Fat Diet–Induced Glucose IntoleranceDiabetes, 2011
- Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failureDiabetologia, 2010
- Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell massDiabetologia, 2010
- β-Cell Failure in Diet-Induced Obese Mice Stratified According to Body Weight Gain: Secretory Dysfunction and Altered Islet Lipid Metabolism Without Steatosis or Reduced β-Cell MassDiabetes, 2010
- Conversion of adult pancreatic α-cells to β-cells after extreme β-cell lossNature, 2010
- Pdx1 ( MODY4 ) regulates pancreatic beta cell susceptibility to ER stressProceedings of the National Academy of Sciences, 2009
- Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Lipotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunBDiabetes, 2009
- The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β CellsCell, 2009